Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-01-28 @ 7:59 PM
Study NCT ID:
NCT02156466
Status:
COMPLETED
Last Update Posted:
2017-01-19
First Post:
2014-05-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multiple Ascending Dose Trial of MSB0010841 (Anti-IL17A/F Nanobody) in Psoriasis Subjects
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08
Start Date Type:
None
Primary Completion Date:
2015-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-05-23
First Submit QC Date:
None
Study First Post Date:
2014-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-08-24
Results First Submit QC Date:
None
Results First Post Date:
2017-01-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-28
Last Update Post Date:
2017-01-19
Last Update Post Date Type:
ESTIMATED